Bimeda Gamrozyne Inj [250ml]

Gamrozyne is the first and only bioequivalent to Zactran^® (gamithromycin) for the treatment and control of Bovine Respiratory Disease (BRD). For use in Beef and Non-lactating Dairy cows to treat and control BRD caused by certain bacteria, including: Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis. Gamithromycin has been proven to reach the target lung tissue within 30 minutes and delivers 10 days of treatment with a single subcutaneous injection. 

Directions: Gamrozyne is administered as a subcutaneous injection in the neck, to be dosed at 2 mL per 110 lbs. of body weight. For total doses exceeding 10 mL divide the dose across multiple injection sites.

Caution: Do not use Gamrozyne in female dairy cattle 20 months of age and older, or in calves intended for veal. Information of the effects of this product on reproductive performance, pregnancy and lactation is not available. The withdrawal period is 35 days prior to slaughter. Gamrozyne should be stored at or below 77º F (25º C).

Bimeda Gamrozyne Inj

• SKU: 36468
• Manufacturer: Bimeda
• Size: 250ml
• For treatment of Bovine Respiratory Disease (BRD)
• Reaches lung tissue of cow within 30 minutes
• 10 days of treatment with a single subcutaneous injection
• Beef and non-lactating dairy cow use only